Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyu Shen

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cellular and Molecular Gastroenterology and Hepatology|June 24, 2026
IGF2BP1-Mediated m6A Modification Stabilizes HMGA2 mRNA to Promote Intrahepatic Cholangiocarcinoma ProgressionYu Guo, Le Zhu, Kaiheng Hu, et al.
Signal Transduction and Targeted Therapy|April 16, 2026
mTOR-driven integrin β4-enriched extracellular vesicles from lenvatinib-resistant hepatocellular carcinoma fuel lung metastasis via fibroblast-niche formationTiantian Zou, Xufeng Wang, Haoting Sun, et al.
Journal of Medicinal Chemistry|October 24, 2024
Evaluation of Double Self-Immolative Linker-Based Antibody-Drug Conjugate FDA022-BB05 with Enhanced Therapeutic PotentialYifan Zhang, Lei Wang, Xuemei Cao, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cellular and Molecular Gastroenterology and Hepatology|June 24, 2026
IGF2BP1-Mediated m6A Modification Stabilizes HMGA2 mRNA to Promote Intrahepatic Cholangiocarcinoma ProgressionYu Guo, Le Zhu, Kaiheng Hu, et al.
Signal Transduction and Targeted Therapy|April 16, 2026
mTOR-driven integrin β4-enriched extracellular vesicles from lenvatinib-resistant hepatocellular carcinoma fuel lung metastasis via fibroblast-niche formationTiantian Zou, Xufeng Wang, Haoting Sun, et al.
Journal of Medicinal Chemistry|October 24, 2024
Evaluation of Double Self-Immolative Linker-Based Antibody-Drug Conjugate FDA022-BB05 with Enhanced Therapeutic PotentialYifan Zhang, Lei Wang, Xuemei Cao, et al.
Pageof 3